Stay updated on Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial
Sign up to get notified when there's something new on the Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial page.

Latest updates to the Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial page
- Check2 days agoChange DetectedThe page now reflects an updated ClinicalTrials.gov frontend revision (v3.5.3) instead of the previous one (v3.5.2), indicating a site release rather than a change to the trial’s content.SummaryDifference0.0%

- Check9 days agoChange DetectedRevision updated: added Revision v3.5.2 and removed Revision v3.5.0.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check38 days agoChange DetectedRevision: v3.5.0 was added. Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check74 days agoChange DetectedThe page now shows Revision: v3.4.2 and no longer displays Revision: v3.4.1, indicating a minor site version update; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check81 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 removed. This appears to be an administrative version update that does not alter study details or navigation on the page.SummaryDifference0.0%

Stay in the know with updates to Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial page.